Piperafizine B exhibits mild cytotoxicity against Moser cells, P388 cells, and vincristine (VCR)-resistant P388 cells (IC50 = 23.8, 22.6, and 23.7 μg/mL, respectively); it acts synergistically with vincristine to enhance VCR-induced cytotoxicity and ameliorate leukemia in a mouse model.